These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8385020)

  • 1. Rapid measurement of blood leakage during regional chemotherapy.
    Alexander C; Omlor G; Berberich R; Gross G; Feifel G
    Eur J Nucl Med; 1993 Mar; 20(3):187-91. PubMed ID: 8385020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized procedure of real-time systemic leakage monitoring during isolated limb perfusion using a hand held gamma probe and 99mTc-HSA.
    Casara D; Rubello D; Pilati P; Scalerta R; Foletto M; Rossi CR
    Nucl Med Commun; 2004 Jan; 25(1):61-6. PubMed ID: 15061266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb.
    Rauschecker HF; Foth H; Michaelis HC; Horst F; Gatzemeier W; Willenbrock C; Voth E; Kahl GF
    Cancer Chemother Pharmacol; 1991; 27(5):379-84. PubMed ID: 1998997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique.
    Cattel L; Buffa E; De Simone M; Cesana P; Novello S; Dosio F; Ceruti M
    Anticancer Res; 2001; 21(3C):2243-8. PubMed ID: 11501854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
    Thompson JF; Gianoutsos MP
    World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities].
    Manner M; Sinn H; Bubeck H; Kettelhack C; Schlag P
    Langenbecks Arch Chir; 1990; 375(4):208-13. PubMed ID: 2395387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leakage measurement during selective limb perfusion using a gamma probe.
    Sandrock D; Horst F; Gatzemeier W; Ghorbani M; Rauschecker H; Munz DL; Emrich D
    Eur J Nucl Med; 1996 May; 23(5):534-8. PubMed ID: 8698058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional hyperthermic perfusion in malignant melanoma of the extremities--controlled studies (proceedings)].
    Hafström L; Jönsson PE
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 723351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regional hyperthermic perfusion with cytostatic agents in malignant melanoma of the extremities (author's transl)].
    Ghussen F; Nagel K; Groth W
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1612-5. PubMed ID: 7308000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
    Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
    Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hyperthermic perfusion in the treatment of tumors of the extremities.
    Di Filippo F; Carlini S; Cavaliere F; Giannarelli D; Cavallero L; Moscarelli F; Aloe L; Cavaliere R
    Adv Exp Med Biol; 1990; 267():223-34. PubMed ID: 2088040
    [No Abstract]   [Full Text] [Related]  

  • 12. [Various aspects of treatment of primary melanoblastoma of the extremities by regional perfusion].
    Schraffordt Koops H; Eibergen R; Oldhoff J; van der Ploegen E; Vermey A
    Ned Tijdschr Geneeskd; 1975 Nov; 119(45):1746-53. PubMed ID: 1214883
    [No Abstract]   [Full Text] [Related]  

  • 13. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
    Ghussen F; Groth W; Nagel K
    Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melphalan perfusion in treatment of melanoma.
    Jönsson PE
    Br J Surg; 1981 May; 68(5):369-70. PubMed ID: 7225765
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
    Didolkar MS; Fitzpatrick JL; Jackson AJ; Johnston GS
    Cancer; 1986 May; 57(10):1961-6. PubMed ID: 3955502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
    Kroon BB; Schraffordt Koops H
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eleven years' experience with hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Anderson RF
    World J Surg; 1979 Jul; 3(3):305-7. PubMed ID: 473783
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
    Kettelhack C; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional chemotherapy for melanoma. A 35-year experience.
    Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
    Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.
    Santinami M; Belli F; Cascinelli N; Rovini D; Vaglini M
    J Surg Oncol; 1989 Nov; 42(3):201-8. PubMed ID: 2811386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.